Skip to main content
. 2021 Oct;13(10):5826–5834. doi: 10.21037/jtd-21-854

Table 1. Demographic and characteristics of 1,254 patients.

Variables Patients
Total (n=1,254) Recurrence (n=22)
Male 759 (60.5) 14 (63.6)
Age, y 61.9±10.1 59.1±10.3
   70≤ age 287 (22.9) 4 (16.0)
Smoking history 561 (44.7) 10 (45.5)
Operation
   Sublobar resection 26 (2.1) 0
   Bilobectomy 88 (7.0) 4 (18.2)
   Lobectomy 1,046 (83.4) 13 (59.1)
   Pneumonectomy 94 (7.5) 5 (22.7)
Histology
   Adenocarcinoma 756 (60.3) 8 (36.4)
   Squamous 393 (31.3) 12 (54.5)
   Mixed 14 (1.1) 1 (4.5)
   Others 91 (7.3) 1 (4.5)
p-N stage
   N0 997 (79.5) 11 (50.0)
   N1 153 (12.2) 6 (27.3)
   N2 104 (8.3) 5 (22.7)
p-stage
   I 860 (68.6) 7 (31.8)
   II 251 (20.0) 9 (40.9)
   IIIa 143 (11.4) 6 (27.3)
RFS, m 115.8±41.1 83.0±19.8
OS, m 116.3±41.0 114.1±34.0
Post-recurrence survival, m 32.9±33.0

Data are presented as number of patients (percentage) or mean ± standard deviation. p-, pathologic; RFS, recurrence-free survival; OS, overall survival.